U.S. top court hears Teva's multiple sclerosis drug patent fight
October 15, 2014 at 01:00 AM EDT
WASHINGTON, Oct 15 (Reuters) - The U.S. Supreme Court on Wednesday is set to wade into Teva Pharmaceutical Industries Ltd's fight over patent protections for Copaxone, its top-selling multiple sclerosis drug, in one of the most important business cases of the justices' new term.
